Organ toxicity and mortality in propofol-sedated rabbits under prolonged mechanical ventilation

• Published in: Anesthesia and analgesia Vol. 105; no. 1; pp. 155 - 166
• Main Authors: YPSILANTIS, Petros, POLITOU, Maria, SIMOPOULOS, Constantinos, MIKROULIS, Dimitrios, PITIAKOUDIS, Michail, LAMBROPOULOU, Maria, TSIGALOU, Christina, DIDILIS, Vasilios, BOUGIOUKAS, Georgios, PAPADOPOULOS, Nikolaos, MANOLAS, Constantinos
• Format: Journal Article
• Language: English
• Published: Hagerstown, MD Lippincott 01.07.2007
• Subjects: Anesthesia; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Animals; Biological and medical sciences; Hypnotics and Sedatives - administration & dosage; Hypnotics and Sedatives - toxicity; Male; Medical sciences; Multiple Organ Failure - chemically induced; Multiple Organ Failure - mortality; Propofol - administration & dosage; Propofol - toxicity; Rabbits; Respiration, Artificial - methods; Time Factors; Vertebrata; Mammalia; General anesthetic; Toxicity; Animal; Mortality; Rabbit; Anesthesia; Propofol; Lagomorpha; Mechanical ventilation
• ISSN: 0003-2999; 1526-7598
• DOI: 10.1213/01.ane.0000265544.44948.0b

Prolonged administration of propofol at large doses has been implicated in propofol infusion syndrome in intensive care unit patients. In this study we investigated organ toxicity and mortality of propofol sedation at large doses in prolonged mechanically ventilated rabbits and determined the role of propofol's lipid vehicle. Eighteen healthy male rabbits were endotracheally intubated and sedated with propofol 2% (Group P), sevoflurane (Group S) or sevoflurane while receiving Intralipid 10% (Group SI). Sedation lasted 48 h or until death (Group P) or the maximum surviving period of Group P (Groups S and SI). The initial propofol infusion rate (20 mg x kg(-1) x h(-1)) or sevoflurane concentration (1.5%) was adjusted, if needed, to maintain a standard level of sedation. Blood biochemical analysis was performed in serial blood samples and histologic examination in the heart, lungs, liver, gallbladder, kidneys, urinary bladder, and quadriceps femoris muscle at autopsy. The mortality rate was 100% (surviving period, 26-38 h) for Group P, whereas 0% for Groups S and SI. The initial propofol infusion rate had to be increased up to 65.7 +/- 4.6 mg x kg(-1) x h(-1) and sevoflurane concentration up to 4%. Serum liver function indices, lipids and creatine kinase were significantly increased (P < 0.05) in Groups P and SI and lactate was increased only in Group P, whereas amylase was increased in all groups. In Group P, histologic examination revealed myocarditis, pulmonary edema with interstitial pneumonia, hepatitis, steatosis, and focal liver necrosis, cholangitis, gallbladder necrosis, acute tubular necrosis of the kidneys, focal loss of the urinary bladder epithelium, and rhabdomyolysis of skeletal muscles; in Group S, low-grade bronchitis and incipient inflammation of the liver and the kidneys; and in Group SI, low-grade bronchitis, liver steatosis and hepatitis, and incipient inflammation of the gallbladder, kidneys, and urinary bladder. Continuous infusion of 2% propofol at large doses for the sedation of rabbits undergoing prolonged mechanical ventilation induced fatal multiorgan dysfunction syndrome similar to the propofol infusion syndrome seen in humans. Our novel findings including lung, liver, gallbladder, and urinary bladder injury were also noted. The role of propofol's lipid vehicle in the manifestation of the syndrome was minor. Sevoflurane proved to be a safe alternative medication for prolonged sedation.